This summary was created by AI, based on 3 opinions in the last 12 months.
UiPath Inc. is recognized as a leading provider of robotics software, especially in the area of agentic AI. This technology operates with less reliance on human prompts compared to traditional generative AI. While the company's growth outlook appears positive, with analysts projecting revenue growth of 11% by 2025, concerns have been raised about the significant decline in share value—approximately 80%—since its initial public offering, which coincided with the surge in demand for robotic solutions during the COVID-19 pandemic. Currently, there's a mixed sentiment on the stock, as some experts are waiting to see profitability before offering an endorsement. Overall, while there are indications of potential recovery, investors should be cautious amidst fluctuating market dynamics and performance issues.
A provider of robotic solutions--robots were a big deal during Covid when this IPO'd. But the growth rate has slid and these shares have slid 80%. 2025 revenue growth is projected at a decent 11%, and AI can help drive growth.
(Analysts’ price target is $15.66)UiPath Inc. is a American stock, trading under the symbol PATH-N on the New York Stock Exchange (PATH). It is usually referred to as NYSE:PATH or PATH-N
In the last year, 1 stock analyst published opinions about PATH-N. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for UiPath Inc..
UiPath Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for UiPath Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered UiPath Inc. In the last year. It is a trending stock that is worth watching.
On 2025-02-14, UiPath Inc. (PATH-N) stock closed at a price of $14.93.
A top provider of robotics software, particularly in agentic AI (which functions less on human prompts that generative AI). Growth looks good ahead.
(Analysts’ price target is $15.79)